Mettler-Toledo International (NYSE:MTD) Given New $1,600.00 Price Target at Barclays

Mettler-Toledo International (NYSE:MTD) had its price target upped by Barclays from $1,350.00 to $1,600.00 in a research report issued on Monday,Benzinga reports. The firm presently has an “overweight” rating on the medical instruments supplier’s stock. Barclays‘s price objective suggests a potential upside of 11.04% from the company’s previous close.

Other equities research analysts also recently issued reports about the stock. Bank of America lifted their price target on shares of Mettler-Toledo International from $1,260.00 to $1,390.00 and gave the company a “neutral” rating in a research report on Monday, September 22nd. Stifel Nicolaus raised their price objective on Mettler-Toledo International from $1,450.00 to $1,600.00 and gave the company a “buy” rating in a research note on Monday. Weiss Ratings reiterated a “hold (c)” rating on shares of Mettler-Toledo International in a research report on Wednesday, October 8th. JPMorgan Chase & Co. upped their price target on shares of Mettler-Toledo International from $1,200.00 to $1,285.00 and gave the company a “neutral” rating in a report on Thursday, October 9th. Finally, Robert W. Baird increased their price objective on Mettler-Toledo International from $1,210.00 to $1,230.00 and gave the company a “neutral” rating in a research note on Monday, August 4th. Five equities research analysts have rated the stock with a Buy rating and seven have assigned a Hold rating to the company. Based on data from MarketBeat.com, the company has a consensus rating of “Hold” and a consensus price target of $1,396.50.

Mettler-Toledo International Stock Performance

Mettler-Toledo International stock traded up $1.54 during midday trading on Monday, reaching $1,440.89. The company’s stock had a trading volume of 48,435 shares, compared to its average volume of 165,166. The firm has a market capitalization of $29.68 billion, a PE ratio of 36.49, a P/E/G ratio of 4.19 and a beta of 1.41. Mettler-Toledo International has a fifty-two week low of $946.69 and a fifty-two week high of $1,454.68. The stock’s 50 day simple moving average is $1,320.50 and its 200 day simple moving average is $1,238.16.

Mettler-Toledo International (NYSE:MTD) last announced its quarterly earnings results on Thursday, November 6th. The medical instruments supplier reported $11.15 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of $10.62 by $0.53. Mettler-Toledo International had a net margin of 21.46% and a negative return on equity of 476.07%. The business had revenue of $1.03 billion during the quarter, compared to the consensus estimate of $997.36 million. During the same quarter last year, the firm posted $10.21 EPS. The business’s revenue was up 7.9% compared to the same quarter last year. Mettler-Toledo International has set its Q4 2025 guidance at 12.680-12.880 EPS. FY 2025 guidance at 42.050-42.250 EPS. Equities analysts predict that Mettler-Toledo International will post 42.71 earnings per share for the current year.

Insider Transactions at Mettler-Toledo International

In related news, Director Thomas P. Salice sold 1,062 shares of the business’s stock in a transaction that occurred on Wednesday, August 13th. The stock was sold at an average price of $1,300.90, for a total transaction of $1,381,555.80. Following the transaction, the director directly owned 283 shares of the company’s stock, valued at approximately $368,154.70. The trade was a 78.96% decrease in their position. The transaction was disclosed in a legal filing with the SEC, which is accessible through the SEC website. Also, CFO Shawn Vadala sold 300 shares of the stock in a transaction dated Tuesday, August 19th. The shares were sold at an average price of $1,325.00, for a total value of $397,500.00. Following the completion of the transaction, the chief financial officer directly owned 5,095 shares of the company’s stock, valued at $6,750,875. This represents a 5.56% decrease in their position. The disclosure for this sale is available in the SEC filing. Insiders sold 1,527 shares of company stock valued at $1,994,981 over the last quarter. Company insiders own 1.94% of the company’s stock.

Institutional Inflows and Outflows

A number of large investors have recently bought and sold shares of MTD. Avalon Trust Co acquired a new position in shares of Mettler-Toledo International in the 3rd quarter valued at about $177,000. Lansforsakringar Fondforvaltning AB publ raised its stake in Mettler-Toledo International by 0.9% during the third quarter. Lansforsakringar Fondforvaltning AB publ now owns 6,487 shares of the medical instruments supplier’s stock worth $7,964,000 after acquiring an additional 57 shares during the period. Citigroup Inc. lifted its holdings in Mettler-Toledo International by 4.8% in the third quarter. Citigroup Inc. now owns 65,033 shares of the medical instruments supplier’s stock worth $79,835,000 after acquiring an additional 2,989 shares during the last quarter. Tredje AP fonden boosted its stake in Mettler-Toledo International by 28.6% in the third quarter. Tredje AP fonden now owns 2,407 shares of the medical instruments supplier’s stock valued at $2,955,000 after acquiring an additional 535 shares during the period. Finally, Stevens Capital Management LP bought a new position in shares of Mettler-Toledo International during the third quarter valued at approximately $438,000. Institutional investors own 95.07% of the company’s stock.

About Mettler-Toledo International

Mettler-Toledo International Inc manufactures and supplies precision instruments and services in the Americas, Europe, Asia, and internationally. It operates through five segments: U.S. Operations, Swiss Operations, Western European Operations, Chinese Operations, and Other. The company’s laboratory instruments include laboratory balances, liquid pipetting solutions, automated laboratory reactors, real-time analytics, titrators, pH meters, process analytics sensors and analyzer technologies, physical value analyzers, density and refractometry, thermal analysis systems, and other analytical instruments; and LabX, a laboratory software platform to manage and analyze data generated from its instruments.